Zearalenone and its five metabolites were analyzed in a population of Tunisian women.
The association between risk of breast cancer and concentration of a-ZAL was evaluated.
The magnitude of associations were estimated by unconditional logistic regression.
Crude and adjusted odds ratios with 95% confidence intervals were calculated.
Results suggest a potential role of a-ZAL in the risk of developing breast cancer.